Lucier named CEO of NuVasive (Healio)
NuVasive recently announced the appointment of Gregory T. Lucier as CEO, effective immediately. Lucier has served as interim CEO since April 1, 2015.
Lucier’s appointment will be in addition to his role as NuVasive’s chairman of the board of directors, of which he has been a member since December 2013, according to a company press release.
“Since being appointed interim CEO, Greg has hit the ground running with an intense focus on driving NuVasive’s industry leadership,” Jack R. Blair, lead independent director of the NuVasive board, said in the release. “...
The Orthopedics Industry 